Market Overview

Option Care Health Completes Reverse Stock Split and Ticker Symbol Change

Share:

BANNOCKBURN, Ill., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that it has completed the reverse 1-for-4 stock split of its shares of common stock, as previously disclosed in the Company's filings with the Securities and Exchange Commission.  As of market open on February 3, 2020, the Company's common stock, which was previously listed on the Nasdaq Capital Market under the symbol "BIOS", will begin trading on a split-adjusted basis on the Nasdaq Global Select Market under the ticker symbol "OPCH" and will be assigned a new CUSIP number (68404L 201).

No other action is required by current stockholders relative to either the ticker symbol change or the reverse stock split.

About Option Care Health

Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 6,000 teammates, including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees. To learn more, please visit our website at OptionCareHealth.com.

For Investor Inquiries:
Bob East, Asher Dewhurst, Jordan Kohnstam
Westwicke
443-213-0500
optioncarehealth@westwicke.com

Primary Logo

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com